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not trigger an inflammatory reaction in
the eye, it can be left in place after trans-
plantation to serve as a basement mem-
brane patch.
The attachment of RPE (see Figure
2), IPE, and/or stem cells onto the
bucky paper may be enhanced by chem-
ically modifying or coating the bucky
paper with one or more biologically ac-
tive substances. The ability to easily
make these modifications may serve as
an important way of optimizing retinal
cell transplantation for macular degen-
eration and retinitis pigmentosa and
may facilitate other ophthalmologic ap-
plications as well.
This patent pending work was performed
by David J. Loftus, Martin Cinke, and
Meyya Meyyappan of Ames Research Cen-
ter, Center for Nanotechnology, and by Har-
vey Fishman, Ted Leng, Philip Huie, and
Kalayaan Bilbao of Stanford University
School of Medicine, Department of Ophthal-
mology. Further information is contained in a
TSP (see page 1).
Inquiries concerning rights for the commer-
cial use of this invention should be addressed
to the Patent Counsel, Ames Research Center,
(650) 604-5104. Refer to ARC-14940.
Using an Ultrasonic Instrument to Size Extravascular Bubbles
Measurements could be used to guide prebreathing of oxygen to reduce the risk of
decompression sickness.
Lyndon B. Johnson Space Center, Houston, Texas
In an ongoing development project,
microscopic bubbles in extravascular tis-
sue in a human body will be detected by
use of an enhanced version of the appa-
ratus described in “Ultrasonic Bubble-
Sizing Instrument” (MSC-22980), NASA
Tech Briefs, Vol. 24, No. 10 (October
2000), page 62. To recapitulate: The
physical basis of the instrument is the
use of ultrasound to excite and measure
the resonant behavior (oscillatory ex-
pansion and contraction) of bubbles.
The resonant behavior is a function of
the bubble diameter; the instrument ex-
ploits the diameter dependence of the
resonance frequency and the general
nonlinearity of the ultrasonic response
of bubbles to detect bubbles and poten-
tially measure their diameters.
In the cited prior article, the applica-
tion given most prominent mention was
the measurement of gaseous emboli (es-
sentially, gas bubbles in blood vessels)
that cause decompression sickness and
complications associated with car-
diopulmonary surgery. According to the
present proposal, the instrument capa-
bilities would be extended to measure
extravascular bubbles with diameters in
the approximate range of 1 to 30 µm.
The proposed use of the instrument
could contribute further to the under-
standing and prevention of decompres-
sion sickness: There is evidence that sug-
gests that prebreathing oxygen greatly
reduces the risk of decompression sick-
ness by reducing the number of micro-
scopic extravascular bubbles. By using
the ultrasonic bubble-sizing instrument
to detect and/or measure the sizes of
such bubbles, it might be possible to pre-
dict the risk of decompression sickness.
The instrument also has potential as a
tool to guide the oxygen-prebreathing
schedules of astronauts; high-altitude
aviators; individuals who undertake
high-altitude, low-opening (HALO)
parachute jumps; and others at risk of
decompression sickness. For example,
an individual at serious risk of decom-
pression sickness because of high con-
centrations of extravascular microscopic
bubbles could be given a warning to con-
tinue to prebreathe oxygen until it was
safe to decompress.
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